Role of androgen and gonadotrophins in the development and function of the Sertoli cells and Leydig cells: data from mutant and genetically modified mice by O'Shaughnessy, P.J. et al.
 
 
 
 
 
 
 
O'Shaughnessy, P.J. and Morris, I.D. and Huhtaniemi, I. and Baker, P.J. 
and Abel, M.H. (2009) Role of androgen and gonadotrophins in the 
development and function of the Sertoli cells and Leydig cells: data from 
mutant and genetically modified mice. Molecular and Cellular 
Endocrinology, 306 (1-2). pp. 2-8. ISSN 0303-7207 
 
http://eprints.gla.ac.uk/30417/ 
 
Deposited on: 03 June 2010 
 
 
Enlighten – Research publications by members of the University of Glasgow 
http://eprints.gla.ac.uk 
Role of androgen and gonadotrophins in the development and function of the Sertoli 
cells and Leydig cells: data from mutant and genetically modified mice 
 
PJ O’Shaughnessy1, ID Morris2, I Huhtaniemi3, PJ Baker1 &  MH Abel4 
 
1Institute of Comparative Medicine 
University of Glasgow Veterinary School 
Bearsden Rd 
Glasgow G61 1QH 
UK 
 
2Hull York Medical School,  
John Hughlings Jackson Building,  
The University of York,  
Heslington,  
York YO10 5DD,  
UK 
 
3Department of Reproductive Biology,  
Imperial College London,  
Hammersmith Campus, 
Du Cane Road,  
London W12 0NN, 
UK 
 
4Department of Physiology, Anatomy and Genetics, 
Le Gros Clarke Building, 
University of Oxford,  
Oxford OX1 3QX 
UK 
 
Correspondence: PJ O’Shaughnessy, Division of Cell Science, University of Glasgow 
Veterinary School, Bearsden Rd, Glasgow G61 1QH, UK. 
e-mail p.j.oshaughnessy@vet.gla.ac.uk  phone ++141 330 5793 
Summary 
Development and maintenance of the male phenotype and establishment of fertility 
are all  dependent upon the activity of the Sertoli cells and Leydig cells of the testis. 
This review examines the regulation and function of these cell during  fetal and post-
natal development.  Fetal Leydig cells are sensitive to both  luteinising hormone (LH) 
and adrenocorticotrophic hormone (ACTH)  but Leydig cell function appears normal 
in fetal mice lacking both hormones or their receptors.  Post-natally,  the Sertoli cells 
and Leydig cells are reliant upon the pituitary gonadotrophins. Leydig cells are 
critically dependent on LH but follicle-stimulating hormone (FSH), presumably acting 
through the Sertoli cell, can also affect Leydig cell function. Testosterone secreted by 
the Leydig cells acts with FSH to stimulate Sertoli cell activity and spermatogenesis. 
Study of animals lacking FSH-receptors and androgen-receptors shows that both 
hormones can act to maintain the meiotic germ cell population but that androgens are 
critical for completion of meiosis.  
 
Introduction 
The testes  are regulated by the pituitary gonadotrophins follicle-stimulating hormone 
(FSH) and luteinising hormone (LH). In the post-natal animal LH stimulates Leydig 
cells to secrete testosterone and both testosterone and FSH act to promote 
spermatogenesis through direct stimulation of the Sertoli cells. Developmental 
changes in circulating hormone levels and some of the major landmarks in testis 
development are shown in Fig 1. Most of this basic description of testicular regulation 
has been known since the 1920s and 1930s, through the pioneering work of Smith, 
Greep and others, (Smith and Engle, 1927; Greep and Fevold, 1937; Walsh et al., 
1934). However, through the introduction of highly purified and recombinant 
gonadotrophins and, more recently, the generation of genetically modified mice 
(Huhtaniemi, 2006) we have been able to define more clearly both the role of these 
hormones and their mechanism of action at the cellular level. This article both reviews 
and presents novel data on the development and hormonal regulation of Leydig cell 
and Sertoli cell function. Our data relates specifically to the mouse but at the end of 
this article we have also tried to show how relevant the mouse is as a model for 
understanding control of testis development and function in the human.   
 
 
Leydig cells 
Fetal Leydig cells 
Fetal Leydig cells first appear in the mouse at about 12.5 days post coitum (dpc), 
developing from mesenchymal-like stem cells within the interstitial space between the 
tubules (Byskov, 1986). Differentiation requires desert hedgehog (DHH), platelet-
derived growth factor (PDGF) (possibly PDGFC) and expression of the X-linked 
Aristaless-related homeobox gene (Arx) (Pierucci-Alves et al., 2001; Yao et al., 2002; 
Brennan et al., 2003; Kitamura et al., 2002). DHH is secreted primarily by the Sertoli 
cells but Pdgfc is not of Sertoli cell origin and Arx expression is limited to peritubular 
myoid cells, endothelial cells and fibroblast-like cells in the fetal testis (Kitamura et 
al., 2002) showing that cells, other than the Sertoli cells, are involved in the 
differentiation process. 
 The fetal Leydig cells are essential regulators of masculinisation. Secretion of 
testosterone acts to rescue and stimulate growth of the male reproductive tract and 
external genitalia while a combination of testosterone and insulin-like growth factor 3 
(INSL3) ensures appropriate testicular descent (Klonisch et al., 2004). In the mouse 
and rat it is not, however,  clear how fetal Leydig cell function is regulated. Postnatal 
Leydig cells are critically dependent on LH  and fetal Leydig cells respond to LH in 
vitro but Leydig cell function is normal in the fetus in the absence of  LH or its 
receptor (O'Shaughnessy et al., 1998; Zhang et al., 2001b; Ma et al., 2004). 
Interestingly, in mice lacking a pituitary gland  through a null-mutation in the T/ebp 
gene, testosterone levels are markedly reduced in late gestation indicating that for 
fetal Leydig cell function to be maintained in the normal range pituitary hormone 
support is essential (Pakarinen et al., 2002).  Levels of  pituitary-derived 
adrenocorticotrophic hormone (ACTH) are high in late fetal life and we have shown 
that fetal Leydig cells express the ACTH receptor (Johnston et al., 2007) and respond  
to ACTH in vitro with an increase in testosterone production (O'Shaughnessy et al., 
2003). Study of mice lacking ACTH showed, however, that fetal testosterone levels 
were normal in these animals and that  ACTH alone was not, therefore, responsible 
for fetal Leydig cell function (O'Shaughnessy et al., 2003). Nevertheless, the 
sensitivity of fetal Leydig cells to both  LH and ACTH raised the possibility that both 
hormones  may act, in a redundant fashion, to regulate fetal testosterone production in 
vivo (ie loss of one hormone or its receptor may be compensated by the presence of 
the other hormone). To test this hypothesis we generated mice lacking both ACTH 
(Pomc-null) and the LH receptor (LuRKO) and measured testosterone levels in late 
fetal and early neonatal development (Fig. 2). Results showed that testosterone levels 
were normal in double knockout mice in late gestation and while there was reduced 
testosterone on the day of birth (day 1) this was not significantly different to LuRKO 
mice. This data indicates that LH and ACTH do not regulate fetal Leydig cell function 
and suggests either that another pituitary hormone is required or that the loss of fetal 
Leydig cell function in the T/ebp-null is not related to the loss of the pituitary and that 
other factors such as extra-pituitary hormones or paracrine factors may be involved. It 
is noteworthy that a number of putative paracrine factors have been shown to regulate 
the steroidogenesis of fetal, but not adult Leydig cells (El Gehani et al., 1998).  
  
Adult Leydig cells 
After birth, at about day 7 in the mouse, a second population of Leydig cells starts to 
differentiate (Baker et al., 1999; Nef et al., 2000). This “adult” population of Leydig 
cells gives rise to the pubertal increase in testosterone levels which is required for 
adult fertility. Unlike the fetal Leydig cell population, the factors regulating adult 
Leydig cell differentiation remain largely unknown. In the absence of DHH and 
PDGFA adult Leydig cells fail to develop but this may be related to a failure of stem 
cell development or proliferation (Clark et al., 2000; Gnessi et al., 2000; Park et al., 
2007). It has been shown that the adult testis contains stem cells which will give rise 
to Leydig cells (Ge et al., 2006) but the origin of these cells and where they reside 
within the normal testis remains unknown. Surprisingly, the immediate progenitors of 
the adult Leydig cells also remain in some doubt. Earlier studies indicated that the 
adult Leydig cells differentiate from peritubular mesenchymal cells (Haider et al., 
1995; Haider and Servos, 1998; Russell et al., 1995; Ariyaratne et al., 2000). A more 
recent study has reported, however,  that Leydig cells develop from perivascular 
smooth muscle cells and pericytes  during normal development or during Leydig cell 
regeneration following ablation with the cytotoxic drug ethane dimethane sulphonate 
(EDS) (Davidoff et al., 2004). To help clarify this apparent contradiction we 
examined expression of a specific marker of Leydig cells (CYP11A1) during the 
regeneration phase after EDS treatment in adult rats (O'Shaughnessy et al., 2008). In 
our studies all cells expressing CYP11A1 were in the peritubular region and we saw 
no evidence of perivascular development of Leydig cells (O'Shaughnessy et al., 
2008). We cannot rule out a perivascular origin for Leydig cells from this evidence, 
and there are other studies suggesting a minor contribution from this source (Haider et 
al., 1995; Haider and Servos, 1998),  but it is unlikely to be the major site of Leydig 
cell precursor differentiation.  
 In contrast to the fetal Leydig cells, the adult Leydig cells are critically 
dependent on LH. There is evidence that the adult Leydig cell population will start to 
differentiate in the absence of LH (Baker et al., 2003; Zhang et al., 2004; Teerds et al., 
2007) but Leydig cell numbers are reduced to about 10% of normal (Baker and 
O'Shaughnessy, 2001) and androgen production is barely detectable (O'Shaughnessy 
et al., 1998; Zhang et al., 2001a; Ma et al., 2004). Androgen also appears to be 
essential for adult Leydig cell function, at least in the mouse (Murphy et al., 1994; 
O'Shaughnessy et al., 2002; Eacker et al., 2008) and there is evidence, going back a 
number of years, that FSH may also play a role in Leydig cell function. The first data 
showed that purified or recombinant FSH would stimulate Leydig cell function in 
hypophysectomised rats (Chen et al., 1976; Kerr & Sharpe, 1985; Teerds et al., 1989; 
Vihko et al., 1991) and this has, since,  been confirmed in the hypogonadal mouse 
(O'Shaughnessy et al., 1992; Sadate-Ngatchou et al., 2004a). In the testis, receptors 
for FSH are only found in the Sertoli cells (Heckert and Griswold, 2002) and the 
effects of FSH must be mediated by a factor or factors released by the Sertoli cells 
which act on the Leydig cells.   
The EDS/Leydig cell regeneration model mentioned above is of use in 
studying regulation of Leydig cell development as the current evidence suggests that 
the regeneration process recapitulates normal development (Teerds & Rijntjes, 2007). 
We have, therefore, used real-time PCR to examine changes in mRNA transcript 
levels of specific signalling molecules during the early phase of Leydig cell 
regeneration (O'Shaughnessy et al., 2008). Results showed that there was a marked 
but transient increase in Pdgfa and Leukemia inhibitory factor (Lif) transcript levels 
24h after treatment with EDS, at a time when Leydig cell ablation was nearly 
complete and regeneration starting (O'Shaughnessy et al., 2008). Both LIF and 
PDGFA are reported to stimulate Leydig cell stem cell proliferation (Ge et al., 2006), 
consistent with a role in Leydig cell regeneration after EDS. Surprisingly there was a 
significant decrease in Dhh levels 24h after EDS treatment which recovered by 48h 
(O'Shaughnessy et al., 2008). Static or declining levels of DHH after EDS treatment 
would suggest that DHH is not involved in the repopulation of adult Leydig cells 
although this requires further study. The EDS model of Leydig cell regeneration 
offers significant advantages in the study of Leydig cell development, not least of 
which is the ability to isolate the event from other developmental changes which 
occur side by side with normal Leydig cell differentiation (Fig 1).  Currently we do 
not know which signals (presumably from the Sertoli cells) trigger  Leydig cell stem 
cell differentiation or, indeed, what stimulates the whole process and a more detailed 
analysis of transcriptional changes during this period is required. 
 
Sertoli cells 
Differentiation and fetal development  
Differentiation of the Sertoli cells signals the start of testis differentiation at around 
11.5dpc in the mouse. The Sertoli cells arise from precursors in the coelomic 
epithelium which covers the developing gonad; they then migrate inwards to form sex 
cords in the differentiating testis (Karl and Capel, 1998). The primordial germ cells 
(PGC) arise in the yolk sac and migrate to the gonad prior to differentiation. As 
testicular differentiation progresses the PGCs become embedded within the sex cords 
which enlarge to form the seminiferous tubules.  Sertoli cell differentiation depends 
on SRY, SOX9 and NR5A1 (Sekido and Lovell-Badge, 2008) and since the Sertoli 
cell is the only cell type which requires the sex-determining gene SRY (Palmer and 
Burgoyne, 1991) it is likely that the Sertoli cell initiates at least the early stages of 
testicular differentiation.  In addition, NR5A1 and SOX9 regulate the transcription of 
anti-Müllerian hormone (AMH) by the Sertoli cells leading to degeneration of the 
paramesonephric (Müllerian) ducts (de Santa et al., 1998). 
 The Sertoli cells proliferate during fetal and early neonatal testicular 
development in the mouse reaching their maximum adult numbers around post natal 
days 15-20 (Vergouwen et al., 1993; Baker and O'Shaughnessy, 2001). Like the fetal 
Leydig cells, the fetal Sertoli cells do not appear to be dependent upon direct 
hormonal stimulation. Sertoli cell number is normal during fetal development in hpg 
mice which lack gonadotrophin-releasing hormone (Baker and O'Shaughnessy, 2001) 
and in follicle-stimulating hormone (FSH) receptor-null (FSHRKO) mice (Johnston et 
al., 2004). In androgen-resistant Tfm mice Sertoli cell number is reduced on the day of 
birth (Johnston et al., 2004) but this is not through a direct effect on the Sertoli cells as 
they do not express androgen receptors (AR) at this time (You and Sar, 1998). 
Instead, it is highly likely that the effects of androgen are mediated through the 
peritubular myoid cells which are AR positive during fetal development  (Tan et al., 
2005; You and Sar, 1998). Analysis of Sertoli cell transcript levels during 
development shows that the transcriptional activity in the cells is generally low during 
the fetal/neonatal proliferative phase and only increases once proliferation starts to 
slow down around day 10 (O’Shaughnessy et al., 2007).  The clear exception to this 
generalisation being AMH which remains high throughout the proliferative phase 
(AlAttar et al., 1997).  There is no evidence of androgen regulation of Sertoli cell 
transcript levels during the fetal period (O'Shaughnessy et al., 2007) but it is not 
currently known whether Sertoli cell function is normal during fetal development  in 
FSHRKO mice. 
  
Post-natal development 
Post-natally, Sertoli cell function can be shown to be androgen- and FSH-sensitive by 
about days 5-6 (Johnston et al., 2004; O'Shaughnessy et al., 2007; Denolet et al., 
2006), coinciding with the slowdown in Sertoli cell proliferation and general increase 
in cell activity. In adult FSHRKO mice Sertoli cell number is reduced but the animals 
are fertile (Dierich et al., 1998; Abel et al., 2000). In contrast, Tfm mice or mice 
lacking androgen receptors (AR) specifically in the Sertoli cells (SCARKO) are 
infertile due to a failure of spermatogenic progression beyond early meiosis (Lyon 
and Hawkes, 1970; De Gendt et al., 2004; Holdcraft and Braun, 2004; Chang et al., 
2004). This highlights the importance of androgens in the regulation of Sertoli cell 
activity and a number of studies have used microarray technology to try to identify the 
major targets of androgen action in the Sertoli cell. These studies have used a variety 
of different models (androgen-treated normal (Zhou et al., 2005), androgen-treated 
hpg (Sadate-Ngatchou et al., 2004b), SCARKO (Denolet et al., 2006), Tfm 
(O'Shaughnessy et al., 2007) and AR hypomorph and Sertoli cell specific knockout 
mice (Eacker et al., 2007)) and the most notable characteristic of the data generated is 
how little consistency there is between the studies.  The only transcript markedly 
altered by androgen action in all studies is Rhox5 (formerly Pem) which is part of the 
reproductive homeobox gene cluster on the X chromosome (Maclean et al., 2005) and  
is known to be highly androgen sensitive (Lindsey and Wilkinson, 1996). The lack of 
consistency between array data is likely to be due to the different models used, to the 
age of the animals which varied from the neonate up to the adult and, possibly, to 
strain differences. These studies should, therefore, be seen as complementary rather 
than contradictory and they suggest that androgen action may change as the Sertoli 
cell matures.  
Despite differences between the array studies they point to at least three 
possible mechanisms of androgen action in the Sertoli cell, maintenance of 
cytoskeletal structure, metabolism of vitamin A and regulation of the Sertoli cell 
(blood-testis) barrier and tubular environment. In mice lacking androgen receptors 
there is misregulation of six transcripts (Rims2, Bin3, Actn3, Cnn3, Nefh, Rai14) 
associated with cytoskeletal structures and regulation of endocytosis and exocytosis 
(Eacker et al., 2007; O'Shaughnessy et al., 2007). In particular, four of these 
transcripts (Bin3, Actn3, Cnn3, and Rai14) have been linked to regulation of the actin 
cytoskeleton. Previous studies have shown  that the actin cytoskeleton of the Sertoli 
cell and the actin-based junctional complexes involved in germ cell adhesion become 
disorganized after hypophysectomy and that this is prevented by androgen (Muffly et 
al., 1993), consistent with a role for androgens in regulating the Sertoli cell 
cytoskeleton. Vitamin A (retinol) is essential for male fertility, and deficiency leads to 
degeneration of spermatogenesis, probably through arrest of normal spermatogonial 
differentiation (Ghyselinck et al., 2006). Two studies have shown that transcripts 
involved in retinoic acid metabolism are regulated by androgen (O’Shaughnessy et al., 
2007; Eacker et al., 2008) raising the possibility that there may be an interaction 
between androgen signaling and the retinoic acid pathway. In the normal testis tight 
junctions between Sertoli cells prevent movement of water-soluble factors into the 
lumen of the seminferous tubule and allows the Sertoli cells to generate a unique 
tubular environment for germ cell development. Data from the arrays and elsewhere 
suggest that this process may be androgen-dependent as androgens are required for 
the formation of the tight junctions and for normal expression of solute carriers  (eg 
Slc38a5, Slc39a8, Slc7a4, Slc4a8, Slc7a7, Slc25a10, Slc35a3) (Meng et al., 2005; 
Fritz et al., 1983; O'Shaughnessy et al., 2007). Loss of androgens or androgen 
receptors may, therefore, disrupt spermatogenesis partly through changes in the 
tubular fluid composition. 
Data from FSHRKO, Tfm and SCARKO mice show that both FSH and 
androgen are essential for normal Sertoli cell function and spermatogenesis. 
Androgens are clearly more critical, however, as spermatogenesis barely progresses 
beyond the pachytene spermatocyte stage in the SCARKO mouse and is even more 
severely disrupted in the Tfm mouse. What is less clear from these models, however, 
is the degree of interaction and redundancy between the effects of FSH and androgen. 
To address this question we have generated mice lacking both AR and FSH receptors 
on the Sertoli cells (FSHRKO.SCARKO)(Abel et al., 2008). In these double 
knockouts Sertoli cell number was not different to FSHRKO mice but there was a 
marked reduction in total germ cell number compared to normal, FSHRKO and 
SCARKO mice. In addition, development of most cells stopped at the early pachytene 
stage with no secondary spermatocytes or round spermatids apparent (Fig 3) (Abel et 
al., 2008). Treating the FSHRKO.SCARKO mouse as a baseline control, the data 
indicates that the primary function of FSH is to increase Sertoli cell number and total 
germ cell number while androgens also act to increase germ cell number but, in 
addition, act to increase germ cell entry into meiosis and increase completion of 
meiosis. Together, the hormones have an additive effect on entry into meiosis and act 
synergistically to stimulate completion of meiosis and entry into spermiogenesis 
(Abel et al., 2008). These results are generally consistent with earlier studies based on 
hormone-replacement regimes (Russell et al., 1993; McLachlan et al., 1995; Singh et 
al., 1995; Haywood et al., 2003) but have the advantage that the  FSHRKO.SCARKO 
mouse is a more clearly defined model of hormone/receptor deficiency and hormone 
action. Analysis of Sertoli cell-specific transcript levels in FSHRKO.SCARKO mice, 
compared to normal, FSHRKO and SCARKO mice, showed that about a third of the 
transcripts measured were independent of hormonal action on the Sertoli cell (Abel et 
al., 2008). Other transcripts measured were either predominantly androgen-dependent 
or showed redundant control by both FSH and androgen (Abel et al., 2008).  
Overall, therefore, the data from FSHRKO.SCARKO mice indicates that both 
hormones can act to maintain the meiotic germ cell population but that androgens are 
critical for completion of meiosis. The Sertoli cell appears to retain a significant 
capacity for hormone-independent action but FSH and androgen act both 
independently and interactively to regulate levels of transcripts encoding factors 
critical for normal germ cell survival and progression.   
 
Is the mouse a good model for human testicular development? 
In general, mouse knockout models which are relevant to the development and 
regulation of testicular function provide reasonably accurate phenocopies of 
respective human mutations. Clearly there are no human equivalents of the cell-
specific AR knockouts described above but the effects of complete AR inactivation on 
spermatogenesis are similar in both mouse and human although the phenotype in the 
human may be more severe with few germ cells present and little progression into 
meiosis (Johnston et al., 2004; Hannema et al., 2006). In both species AR-null 
individuals are cryptorchid and  the phenotype of AR-null  testis is very similar to the 
cryptorchid testis (Johnston et al., 2004; Hedinger 1982). Differences between the 
AR-null mouse and human testis may, therefore, be at least a partial reflection of their 
sensitivity to elevated temperature. As discussed above,  mouse FSHβ (Kumar et al., 
1997) and FSHR (Abel et al., 2000; Dierich et al., 1998) knockout phenotypes are 
both fertile with slight reduction of sperm quality. Inactivating mutations of FSHβ  in 
humans cause azoospermia (Layman et al., 2002; Lindstedt et al., 1998; Phillip et al., 
1998), but individuals with FSHR inactivation are oliozoospermic, and some have 
even sired children (Tapanainen et al., 1997). The exact human phenotype of FSH 
inactivation therefore remains unclear. The most conspicuous different between men 
and mice is the phenotype of LHR inactivation. LHR knockout mice are normally 
masculized at birth (Zhang et al., 2001a) whereas humans with completely 
inactivating LHR mutation are pseudohermaphrodites, totally or near-totally lacking 
masculinization in utero (Huhtaniemi and Themmen, 2005; Themmen and 
Huhtaniemi, 2000).  Functional LHR in humal fetal Leydig cells is thus compulsory 
for their androgen synthesis, whereas in the mouse, as discussed above, paracrine or 
other endocrine factors must be able to maintain sufficient androgen synthesis by the 
fetal Leydig cells to induce masculinisation. The same species difference in fetal 
Leydig cell function is not, however, found in the case of LH inactivation (Lofrano-
Porto et al., 2007; Valdes-Socin et al., 2004; Weiss et al., 1992; Ma et al., 2004)). In 
the human, placental hCG (an agonist of LH) can take over the function of missing 
LH while in the mouse, as we have shown, a number of different factors are able to 
compensate for missing LH. It is interesting that the two mammalian species have 
both developed backup mechanisms to compensate for missing LH action in the 
support of intrauterine masculinisation although the two mechanisms appear to be 
completely different. 
 
Conclusions and future directions 
The use of mutant and transgenic mice and the development of convenient, high 
throughput methods for measuring transcript and protein levels have significantly 
increased our understanding of testis development in recent years. A number of key 
factors regulating testicular cell differentiation have been identified and the 
mechanisms underlying pituitary hormone and androgen control of testis development  
have become more established. There remain, of course, a number of outstanding gaps 
in our knowledge which need to be the targets of further study. For example, the 
nature and importance of interactions between the different cell types in the testis 
remains uncertain. Leydig cells regulate Sertoli cell function through secretion of 
androgens but how do Sertoli cells regulate Leydig cells and is this of physiological  
importance in the normal adult? What is the role of the peritubular myoid cells in 
testis development and function?  How is fetal Leydig cell function controlled? These 
questions and others are likely to be answered in the near future by the increasing use 
and generation of mouse models which target gene ablation to specific cell types 
during testis development (eg Lecureuil et al., 2002).  
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Figure Legends 
 
Figure 1 
Relative changes in circulating hormone levels during development in the male 
mouse. The approximate timing of landmark events in the development of the testis is 
shown by vertical arrows. 
A  Testis differentiation 
B  Fetal Leydig cell differentiation 
C  Spermatogonial differentiation 
D  Adult Leydig cell differentiation 
E  Onset of meiosis 
F  End of Sertoli cell proliferation 
G  Formation of Sertoli cell barrier 
H  Testis Descent 
I   Mature sperm present in testis 
 
Figure 2 
Intratesticular testosterone levels in normal (control), LuRKO, POMC-null (POMC) 
and LuRKO/POMC-null (LuRKO.POMC) mice. Intratesticular testosterone levels 
were measured on day 18 post coitum (A) and on post-natal day 1 (B). Results show 
the mean ± sem of 3 to 8 animals in each group. Two factor analysis of variance was 
used to analyse the data at each age. At  post-coitum day 18 there was no difference 
between groups. At day 1 there was a significant effect of the LuRKO modification (* 
P<0.05)  but no effect of POMC-null and no interaction. 
 
Figure 3 
Histology of teses from 8-wk-old normal, FSHRKO, SCARKO, and 
FSHRKO.SCARKO mice. Semi-thin sections stained with toluidine blue are shown 
and the bar represents 20μm. The tubules of normal and FSHRKO mice contained all 
stages of spermatogenesis although germ cell number was reduced in the FSHRKO 
mice. In SCARKO mice, spermatogenesis progressed through meiosis, but there was 
progressive loss of pachytene spermatocytes, and few secondary spermatocytes or 
round spermatids were observed. In FSHRKO.SCARKO mice, the tubular lumens 
were narrow and contained a high concentration of  Sertoli cells (SC) with a smaller 
number of spermatogonia (S). Spermatogonia entered meiosis, but development 
stopped at early pachytene in most cells. Abundant Leydig cells (LC) were present 
within the interstitium. 
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